BCL2 and neoplasm: SLAMF7+ DNT exhibited significantly higher expression of the proliferation marker Ki67 and the anti-apoptotic marker BCL2, accompanied by a reduced apoptosis rate (Fig. 4A and B), confirming that SLAMF7 promotes DNT survival and tumor-infiltrating capacity.